Dietary supplements in polycystic ovary syndrome-current evidence.

PCOS dietary supplement infertility metabolic issues treatment options

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 28 06 2024
accepted: 09 09 2024
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in women of reproductive age, and presents a significant challenge to the global population. This review provides comprehensive evidence of interventions, including food and dietary supplements, aimed at reversing PCOS and improving fertility outcomes. Various dietary supplements are known to cause metabolic changes and hormonal regulation and have a potential impact on increasing pregnancy rates. Although some biochemical alterations have been observed, these metabolic changes do not directly reverse the disorder. Moreover, the lack of sufficient evidence does not convince clinicians to standardize dietary supplements as alternatives to medical or pharmacological interventions. This calls for a study of women with PCOS taking dietary supplements. In addition, unbiased studies of combinations of treatment options for supplements, including large cohort clinical trials, will lead to evidence-based medicine.

Identifiants

pubmed: 39398335
doi: 10.3389/fendo.2024.1456571
pmc: PMC11466749
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1456571

Informations de copyright

Copyright © 2024 Han, Hou, Han, Yuan and Chen.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Ya Han (Y)

School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin, China.
Department of Integrative Chinese and Western Medicine, Xin Cheng Health Care Hospital, Daqing, China.

Ye Hou (Y)

Department of Integrative Chinese and Western Medicine, Xin Cheng Health Care Hospital, Daqing, China.

Qimao Han (Q)

Department of Rheumatology, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

Xingxing Yuan (X)

School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin, China.
Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, China.

Lu Chen (L)

Department of Gynecology II, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH